Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation

S. Paz (San Diego, United States of America), M. Julian (Columbus, United States of America), D. Siefker (San Diego, United States of America), E. Escobedo (San Diego, United States of America), C. Polizzi (San Diego, United States of America), M. Ferrer (San Diego, United States of America), L. Guy (San Diego, United States of America), C. Burkart (San Diego, United States of America), R. Adams (San Diego, United States of America), L. Nangle (San Diego, United States of America), E. Crouser (San Diego, United States of America)

Source: Virtual Congress 2021 – Better understanding of sarcoidosis: new keys
Session: Better understanding of sarcoidosis: new keys
Session type: Oral Presentation
Number: 3986

Congress or journal article abstractWebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Paz (San Diego, United States of America), M. Julian (Columbus, United States of America), D. Siefker (San Diego, United States of America), E. Escobedo (San Diego, United States of America), C. Polizzi (San Diego, United States of America), M. Ferrer (San Diego, United States of America), L. Guy (San Diego, United States of America), C. Burkart (San Diego, United States of America), R. Adams (San Diego, United States of America), L. Nangle (San Diego, United States of America), E. Crouser (San Diego, United States of America). Late Breaking Abstract - Immunomodulatory protein ATYR1923 disrupts an in vitro model of sarcoid granuloma formation. 3986

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Copper-heparin counteracts elastase-induced emphysema formation
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Late Breaking Abstract - Pharmacological characterization of T cell-induced broncho-constriction in vitro and in vivo
Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD
Year: 2018



Late Breaking Abstract - Role of interleukin-10 in normal and aberrant late lung development
Source: International Congress 2017 – Postnatal lung growth and development
Year: 2017

Late Breaking Abstract - Novel mesenchymal pathways that initiate emphysema
Source: International Congress 2018 – Intercellular communication in tissue remodelling
Year: 2018




Late Breaking Abstract: Activation of the WNT/β-catenin pathway attenuates experimental emphysema
Source: Annual Congress 2010 - Novel cellular mechanisms in lung disease
Year: 2010


Late Breaking Abstract - Caveolin-1 derived peptide LTI-03 promotes epithelial cell survival and attenuates pulmonary fibrosis
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
Year: 2019

Late Breaking Abstract -  Effect of Hypercapnia in human primary culture of alveolar cells in vitro
Source: International Congress 2018 – Preclinical and clinical studies of critical illness
Year: 2018

Late Breaking Abstract - SARS-CoV-2 induces hyperinflammation in human macrophages via TLR4
Source: Virtual Congress 2021 – Late breaking basic and translational science of SARS-Cov2 and COVID-19
Year: 2021



Late Breaking Abstract - Plasma cells and endothelitis in COVID-19 lung pathology
Source: Virtual Congress 2020 – Covering COVID - the best abstracts
Year: 2020

Late Breaking Abstract - Elevated NETosis and migration but impaired anti-microbial responses by COVID-19 neutrophils
Source: Virtual Congress 2021 – Acute COVID - 19
Year: 2021



Late Breaking Abstract - Mammalian target of rapamycin orchestrates eosinophil development in bone marrow
Source: International Congress 2017 – Animal models of asthma and allergies
Year: 2017


Late Breaking Abstract - Treatment with ATYR1923 reduces biomarkers in COVID-19 pneumonia
Source: Virtual Congress 2021 – Diagnosis and management of COVID-19
Year: 2021


Late Breaking Abstract - Assessment of a ciliary transport protein in airway cells reveals novel pattern in cystic fibrosis
Source: International Congress 2017 – Cystic fibrosis: clinical issues
Year: 2017


Late Breaking Abstract - Title: Air-born allergens modulate the immunological lung microenvironment.
Source: International Congress 2017 – Novel mechanisms in asthma
Year: 2017

Late Breaking Abstract - Mapping fibroblast activity in IPF– the instructive lung ECM
Source: Virtual Congress 2020 – Translational therapeutic advances
Year: 2020


Late Breaking Abstract: Cathelicidin has direct anti-rhinoviral activity
Source: Annual Congress 2010 - Cell biology and immunology of lung disease
Year: 2010


Late Breaking Abstract - Roles for transglutaminases in normal and aberrant lung development associated with BPD.
Source: International Congress 2017 – Late-breaking findings in pulmonary diseases
Year: 2017

Late Breaking Abstract: The role of galectin-3 on macrophages in CNT-induced mouse lung inflammation
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010

Late Breaking Abstract - MIF inhibition in a murine model of bleomycin-induced lung fibrosis
Source: International Congress 2018 – Molecular mechanisms and treatment of pulmonary hypertension
Year: 2018



Late Breaking Abstract - TGF-ß impairs fibroblast ability to support lung organoid formation: pharmacological restoration by GSK-3 inhibition and secreted niche factor supplementation
Source: International Congress 2018 – New pharmacological strategies in airway diseases
Year: 2018